专家意见在推荐急性冠状动脉综合征患者早期强化降脂治疗中的价值。 - Suppr

Value of expert opinion in recommending early intensive lipid lowering in patients with ACS.

作者信息

White Harvey D

机构信息

Te Whatu Ora - Health New Zealand, Te Toka Tumai Auckland, Green Lane Cardiovascular Research Unit, Auckland City Hospital, Auckland, New Zealand.

出版信息

Eur Heart J Acute Cardiovasc Care. 2022 Dec 27;11(12):936-938. doi: 10.1093/ehjacc/zuac136.

DOI:10.1093/ehjacc/zuac136

PMID:36574352

Abstract

摘要

相似文献

Value of expert opinion in recommending early intensive lipid lowering in patients with ACS.专家意见在推荐急性冠状动脉综合征患者早期强化降脂治疗中的价值。

Eur Heart J Acute Cardiovasc Care. 2022 Dec 27;11(12):936-938. doi: 10.1093/ehjacc/zuac136.

Benefits of intensive lipid-lowering therapies in patients with acute coronary syndrome: a systematic review and meta-analysis.急性冠脉综合征患者强化降脂治疗的获益：系统评价和荟萃分析。

Ann Med. 2024 Dec;56(1):2389470. doi: 10.1080/07853890.2024.2389470. Epub 2024 Aug 10.

Lipid-lowering treatment up to one year after acute coronary syndrome: guidance from a French expert panel for the implementation of guidelines in practice.急性冠脉综合征后降脂治疗一年：法国专家组对指南实施的指导意见。

Panminerva Med. 2023 Jun;65(2):244-249. doi: 10.23736/S0031-0808.22.04777-2. Epub 2022 Oct 12.

Early, Intensive and Persistent Lipid-Lowering Therapy for Secondary Prevention of Acute Coronary Syndrome.急性冠状动脉综合征二级预防的早期、强化和持续降脂治疗。

J Atheroscler Thromb. 2024 Dec 1;31(12):1748-1762. doi: 10.5551/jat.64988. Epub 2024 Jun 15.

More intensive lipid lowering is associated with regression of coronary atherosclerosis in diabetic patients with acute coronary syndrome--sub-analysis of JAPAN-ACS study.更强化的降脂治疗与急性冠脉综合征合并糖尿病患者冠状动脉粥样硬化的消退相关--JAPAN-ACS 研究的亚组分析。

J Atheroscler Thromb. 2010 Oct 27;17(10):1096-107. doi: 10.5551/jat.5660. Epub 2010 Jul 28.

Lipid Lowering Drugs in Acute Coronary Syndromes (ACS).急性冠状动脉综合征（ACS）中的降脂药物。

Curr Atheroscler Rep. 2023 Dec;25(12):939-946. doi: 10.1007/s11883-023-01163-6. Epub 2023 Nov 28.

Vulnerable plaque derived from aspirated thrombi in recurrent acute coronary syndrome with familial hypercholesterolemia despite intensive lipid-lowering statin therapy.尽管接受了强化降脂他汀类药物治疗，但在患有家族性高胆固醇血症的复发性急性冠状动脉综合征中，源自吸出血栓的易损斑块。

Cardiol J. 2022;29(2):362-363. doi: 10.5603/CJ.2022.0018.

[Statins in the management of acute coronary syndrome].[他汀类药物在急性冠状动脉综合征管理中的应用]

Nihon Rinsho. 2010 Apr;68(4):692-8.

Lipid Management in Patients Presenting With Acute Coronary Syndromes: A Review.急性冠状动脉综合征患者的血脂管理：综述。

J Am Heart Assoc. 2020 Dec 15;9(24):e018897. doi: 10.1161/JAHA.120.018897. Epub 2020 Dec 8.

[The expanding needs on lipid-lowering treatment in patients with acute coronary syndrome by applying newly issued definition of extreme high-risk by Chinese Society of Cardiology].[应用中国心脏病学会新发布的极高危定义看急性冠状动脉综合征患者降脂治疗需求的不断增加]

Zhonghua Xin Xue Guan Bing Za Zhi. 2020 Dec 24;48(12):1039-1046. doi: 10.3760/cma.j.cn112148-20200710-00549.

引用本文的文献

Efficacy and Safety of PSCK9 Inhibitors on Patients with Acute Coronary Syndrome: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.前蛋白转化酶枯草溶菌素9（PCSK9）抑制剂对急性冠状动脉综合征患者的疗效和安全性：一项随机对照试验的系统评价和荟萃分析

Rev Cardiovasc Med. 2024 Mar 7;25(3):94. doi: 10.31083/j.rcm2503094. eCollection 2024 Mar.

Early, Intensive and Persistent Lipid-Lowering Therapy for Secondary Prevention of Acute Coronary Syndrome.急性冠状动脉综合征二级预防的早期、强化和持续降脂治疗。

J Atheroscler Thromb. 2024 Dec 1;31(12):1748-1762. doi: 10.5551/jat.64988. Epub 2024 Jun 15.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Value of expert opinion in recommending early intensive lipid lowering in patients with ACS.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献